메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한암학회 Cancer Research and Treatment Cancer Research and Treatment 제46권 제3호
발행연도
2014.1
수록면
261 - 269 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
PurposeThe purpose of this study is to evaluate the outcome of low-dose whole brain radiotherapy(WBRT) with tumor bed boost after methotrexate-based chemotherapy in themanagement of primary central nervous system lymphoma (PCNSL). Materials and MethodsWe retrospectively analyzed 64 patients with pathologically proven PCNSL between2000 and 2011. Methotrexate-based chemotherapy with a median of five cycles wasfollowed by radiotherapy to the whole brain and to the initial tumor bed. The mediandose to the whole brain and to the tumor bed was 27 Gy (range, 18 to 36 Gy) and 50.4Gy (range, 45 to 54 Gy), respectively. ResultsWith a median follow-up period of 27 months, 55 patients (85.9%) achieved completeresponse (CR). The 5-year overall survival (OS) and progression-free survival (PFS)rates were 52.6% and 39.3%, respectively. In univariate analysis, factors associatedwith OS were age, performance status, involvement of deep structure, and CR tosequential chemoradiotherapy (CRT). These variables remained as significant factorsfor OS in multivariate analysis. CR to sequential CRT was the only positive factor associatedwith PFS (p=0.009). Neurologic toxicity was more common in elderly patientsolder than 60 years (p=0.025). ConclusionLow-dose WBRT with tumor bed boost after methotrexate-based chemotherapy mightbe an effective method for management of PCNSL.

목차

등록된 정보가 없습니다.

참고문헌 (19)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0